Keith Erdman

606 total citations
9 papers, 504 citations indexed

About

Keith Erdman is a scholar working on Infectious Diseases, Virology and Nephrology. According to data from OpenAlex, Keith Erdman has authored 9 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Nephrology. Recurrent topics in Keith Erdman's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Gastroesophageal reflux and treatments (2 papers). Keith Erdman is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Gastroesophageal reflux and treatments (2 papers). Keith Erdman collaborates with scholars based in United States, United Kingdom and Sweden. Keith Erdman's co-authors include G. Richard Granneman, John M. Leonard, Ann Hsu, Eugene Sun, Guoliang Cao, Paolo Baroldi, J.W.M. ter Berg, Anthony J. Japour, Tawakol A. El‐Shourbagy and Akhteruzzaman Molla and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Keith Erdman

9 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Erdman United States	7	327	234	111	96	96	9	504
Catherine Gillotin France	15	278 0.9×	171 0.7×	86 0.8×	72 0.8×	112 1.2×	26	616
D.M. Burger Netherlands	12	364 1.1×	193 0.8×	106 1.0×	48 0.5×	49 0.5×	27	461
William D. Fiske United States	11	309 0.9×	209 0.9×	83 0.7×	90 0.9×	99 1.0×	17	544
Monique M. R. de Maat Netherlands	10	431 1.3×	229 1.0×	121 1.1×	56 0.6×	85 0.9×	15	606
Samuel Thomas United States	6	279 0.9×	147 0.6×	83 0.7×	62 0.6×	64 0.7×	11	421
C. J. L. la Porte Canada	11	433 1.3×	201 0.9×	129 1.2×	76 0.8×	62 0.6×	16	546
Aurélie Fayet Switzerland	9	408 1.2×	254 1.1×	111 1.0×	86 0.9×	69 0.7×	11	552
Richard Granneman United States	11	331 1.0×	190 0.8×	277 2.5×	108 1.1×	113 1.2×	18	677
Steve West United States	7	339 1.0×	195 0.8×	71 0.6×	39 0.4×	55 0.6×	9	408
Sara E. Gibbons United Kingdom	9	485 1.5×	330 1.4×	125 1.1×	52 0.5×	51 0.5×	13	594

Countries citing papers authored by Keith Erdman

Since Specialization

Citations

This map shows the geographic impact of Keith Erdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Erdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Erdman more than expected).

Fields of papers citing papers by Keith Erdman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Erdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Erdman. The network helps show where Keith Erdman may publish in the future.

Co-authorship network of co-authors of Keith Erdman

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Erdman. A scholar is included among the top collaborators of Keith Erdman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Erdman. Keith Erdman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Roy, Michael J., et al.. (2013). Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment. Clinical Pharmacokinetics. 52(5). 385–395. 6 indexed citations

Erdman, Keith, et al.. (2007). Absence of Food Effect on the Extent of Alprazolam Absorption from an Orally Disintegrating Tablet. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1120–1124. 4 indexed citations

Khosravan, Reza, et al.. (2005). Effect of febuxostat on pharmacokinetics of desipramine, a CYP2D6 substrate, in healthy subjects. Clinical Pharmacology & Therapeutics. 77(2). P43–P43. 16 indexed citations

Chun, Alexander, Keith Erdman, Yi‐Lin Chiu, et al.. (2002). Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation. Clinical Therapeutics. 24(8). 1322–1331. 15 indexed citations

Chun, Alexander, Keith Erdman, Yiming Zhang, Ramanuj Achari, & John H. Cavanaugh. (2000). Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods. Clinical Therapeutics. 22(2). 231–236. 16 indexed citations

Hsu, Ann, G. Richard Granneman, Guoliang Cao, et al.. (1998). Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*. Clinical Pharmacology & Therapeutics. 63(4). 453–464. 135 indexed citations

Hsu, Ann, G. Richard Granneman, Guoliang Cao, et al.. (1998). Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 42(11). 2784–2791. 130 indexed citations

Hsu, Ann, G. Richard Granneman, Galen Witt, et al.. (1997). Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects. Antimicrobial Agents and Chemotherapy. 41(5). 898–905. 158 indexed citations

Granneman, G. Richard, Rene A. Braeckman, & Keith Erdman. (1995). Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid Chromatography. Clinical Pharmacokinetics. 29(Supplement 2). 1–8. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact